Compare RLMD & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLMD | BBW |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 461.9M | 473.7M |
| IPO Year | 2012 | 2004 |
| Metric | RLMD | BBW |
|---|---|---|
| Price | $4.37 | $29.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $12.40 | ★ $67.71 |
| AVG Volume (30 Days) | ★ 1.1M | 602.0K |
| Earning Date | 05-08-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 2.51% |
| EPS Growth | ★ 45.28 | 5.00 |
| EPS | N/A | ★ 1.45 |
| Revenue | $13,070.00 | ★ $357,866,000.00 |
| Revenue This Year | N/A | $5.63 |
| Revenue Next Year | N/A | $4.62 |
| P/E Ratio | ★ N/A | $19.61 |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $1.06 | $27.50 |
| 52 Week High | $8.00 | $75.77 |
| Indicator | RLMD | BBW |
|---|---|---|
| Relative Strength Index (RSI) | 32.21 | 33.67 |
| Support Level | $4.29 | $29.35 |
| Resistance Level | $4.92 | $39.89 |
| Average True Range (ATR) | 0.19 | 2.12 |
| MACD | 0.02 | -0.95 |
| Stochastic Oscillator | 25.40 | 17.71 |
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.